Merck Stops Developing COVID Vaccine: Better Immunity Found Through ‘Natural Infection’, by Michael Haynes

Joe Biden Calls Himself a “Savior Around the World” for Forcing Americans to Fund Planned Parenthood. by Micaiah Bilger

January 30, 2021

New Study Shows Hydroxychloroquine ‘May Be a Benefit’ in Treating the Coronavirus After All, by Emma Colton

January 30, 2021

Merck headquartersShutterstock

Merck will now focus instead on two therapeutic drugs, termed MK-7110 and MK-4482.

By Michael Haynes, LifeSiteNews, Jan 29, 2021

Big Tech is censoring us. Subscribe to our email list and bookmark LifeSiteNews.com to continue getting our news. Subscribe now.

WASHINGTON, D.C., January 29, 2021 (LifeSiteNews) — U.S.-based vaccine company Merck announced it is stopping all further development on both of its COVID-19 vaccines since the results gave less protection than was gained from “natural infection.”

Merck, or MSD outside of the United States and Canada, announced the news in a press release a few days ago, saying all production and development on both of its vaccine candidates would cease. Both candidates were made in conjunction with other companies: V590 was a joint project with IAVI, and V591 was being developed with Institut Pasteur and Themis. …

Continue reading >>>>